In summary, the coordinance between reduced or loss of expression of BRMS1 and clinico-pathological features of breast cancer was significant enough to suggest that BRMS1 could be an indicator of the metastatic capacity and low expression of the protein in regards to the poor prognosis surrounding breast cancer. Here, BRMS1 is linked to breast carcinoma.